Press Releases

Immunexpress to Present Data on Utility of SeptiCyte™ LAB for Diagnosing Sepsis at the Pathology Diagnostics Conference

Immunexpress.com

Immunexpress to Present Data on Utility of SeptiCyte™ Lab for Diagnosing Sepsis at the Pathology Diagnostics Conference SeptiCyte™ Lab Quantifies Host Molecular Markers to Aid Physicians in the Diagnosis of Sepsis in Critical Care Patients SEATTLE, June 4, 2015 – Immunexpress, Inc. today announced that Dr. Antony Rapisarda, Director Medical Affairs, will present data at…

Read More

Immunexpress to Present Data on the Early Diagnosis of Sepsis with SeptiCyte™ LAB at the Next Generation Diagnostics Summit

Immunexpress.com

SEATTLE, Aug. 12, 2015 – Immunexpress, Inc. today announced that Dr. Therese Seldon, Vice President of Operations, will present data on the utility of its SeptiCyte® Lab test to aid in the clinical assessment of sepsis in critical care patients at the Next Generation Diagnostics Summit on Aug. 19 in Washington, D.C. The presentation will…

Read More

Immunexpress Supports World Sepsis Day 2015

Immunexpress.com

Call for Action on Sept. 13 Includes Awareness, Education and Funding Initiatives to Help Reverse Global Increase in Numbers of Deaths from Sepsis    Video Interviews on the Immunexpress Website Highlight the Need for Faster Diagnosis of Sepsis  SEATTLE, Sept. 10, 2015 –  Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected…

Read More

Immunexpress Presents Results Indicating the Utility of SeptiCyte™ for the Diagnosis of Sepsis in Critically Ill Children at the 45th Annual Society of Critical Care Medicine Congress

Immunexpress.com

Additional Results from the VENUS A Study Further Validate SeptiCyte as a Diagnostic Assay for Sepsis in Critically Ill Adults SEATTLE, Feb. 22, 2016 /PRNewswire/ — Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced the presentation of data on the utility of SeptiCyte™ LAB in both adult and…

Read More

Immunexpress Announces Presentations at the 45th Annual Society of Critical Care Medicine Congress on the Utility of SeptiCyte™ LAB

Immunexpress.com

SEATTLE, Feb. 10, 2016 /PRNewswire/ — Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced that data on the utility of SeptiCyte® Lab in both adult and pediatric populations to aid in the clinical assessment of sepsis in critical care patients will be presented at the upcoming 45th Annual…

Read More

Immunexpress Strengthens Board of Directors with Key Appointments

Immunexpress.com

Accomplished Industry Leaders Join Recently Appointed CEO, Dr. Rolland Carlson, to Expand on the Comprehensive Experience of the Board SEATTLE, May 15, 2018 /PRNewswire/ — Immunexpress, Inc. today announced the appointment of three new members to its Board of Directors. Rolland Carlson, PhD, Tanja Dowe and Katleen Verleysen, PhD, have joined the company’s board, while Bea Arnold, PhD, has stepped down from the board after…

Read More

Immunexpress Releases Key Performance Data on SeptiCyte™ LAB in PLOS Medicine Publication

Immunexpress.com

SEATTLE, Dec. 8, 2015 /PRNewswire/ — Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, announced today the publication of the discovery and validation of the SeptiCyte® Lab test for sepsis in PLOS Medicine. SeptiCyte® Lab is a rapid molecular assay that measures a patient’s gene expression level to differentiate between sepsis…

Read More

Immunexpress Appoints Dr. Roy Davis Chief Medical Officer

Immunexpress.com

SEATTLE, Oct. 22, 2015 – Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced the  appointment of Roy F. J. Davis, Ph.D., M.D., M.H.A., as Chief Medical Officer. “Dr. Davis has over 30 years of experience providing and directing patient care for multiple healthcare-provider organizations,” said Roslyn Brandon,…

Read More

Immunexpress Appoints Dr. Bea Arnold to Board of Directors

Immunexpress.com

SEATTLE, Sept. 29, 2015 – Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced that Dr. Bea Arnold has joined the Company’s Board of Directors. “We are delighted to welcome Dr. Arnold to our Board of the Directors,” said Roslyn Brandon, President and CEO of Immunexpress. “Debiopharm is…

Read More

Immunexpress to Present Data on SeptiCyte™ at the “Meeting of Experts on Biomarkers to Discriminate Bacterial from Other Infectious Causes of Acute Fever”

Immunexpress.com

SEATTLE, Sept. 16, 2015 –  Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, announced today that Dr. Therese Seldon, Vice President of Operations, will present data on SeptiCyte® technology at the “Meeting of Experts on Biomarkers to Discriminate Bacterial from Other Infectious Causes of Acute Fever” on Sept. 22…

Read More